Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) represented a move of 4.89 percent or $-3.72 per share and closed its previous day trading session at $56.02. 1.45 Million Shares were traded in the last trading session with an Average Volume of 861.96 Million Shares. The stock currently has a Market Capitalization of 1.38 Billion.
Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company’s lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR). OCA is initially being developed for the second line treatment of primary biliary cirrhosis (PBC). Intercept Pharmaceuticals Inc. is headquartered in New York.
The stock traded between $ 51.05 and $135.59 over 1-Year time period showing its price to sales ratio of 12.91. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-5.87 and 200-Day Simple Moving Average of $-36.77. Its Price to Free Cash Flow is 0 and Price to Book of 12.59.
Analyst’s recommended the stock as 2.5 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) reported its Actual EPS of $-4.43/share. The analysts offering Earnings Estimates for the company were believing that Intercept Pharmaceuticals, Inc. could bring EPS of $-3.55/share. The difference between Actual EPS and Estimated EPS was -0.88 Percent. Thus showing an Earnings Surprise of -24.8 Percent.
Franklin Street Properties Corp. (NYSE:FSP)
In the last trading session, Franklin Street Properties Corp. (NYSE:FSP) added its value by -10.28% closing at the price of $8.55. The stock currently has market capitalization of 900.49 Million, with average volume of 416.63 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Franklin Street Properties Corp. (NYSE:FSP) is showing beta of 0.67. This particular value of beta suggests that Franklin Street Properties Corp. (NYSE:FSP) has historically moved 67% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Franklin Street Properties Corp. (NYSE:FSP) is at $-0.09.
The stock currently has RSI of 23.45. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Franklin Street Properties Corp., a real estate investment trust, is focused on investing in institutional-quality office properties in major U.S. markets. FSP’s strategy is to invest in select urban infill and central business district (CBD) properties, with primary emphasis on their top five markets of Atlanta, Dallas, Denver, Houston, and Minneapolis. FSP seeks value-oriented investments with an eye towards long-term growth and appreciation, as well as current income. FSP’s primary real estate operations include property acquisitions and dispositions, leasing, development and asset management. FSP has also been a cyclical investor in San Diego, Silicon Valley, Greater Boston, Raleigh-Durham, and Greater Washington, DC, and will continue to monitor these markets, as well as other markets, for opportunistic investments.
Franklin Street Properties Corp. (NYSE:FSP) topped its 52-week high price of $12.84 on 02/28/17 and 52-Week Low Price of $ 8.55 on 02/14/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.04% and monthly volatility of 3.02% respectively.